Neuberger Berman Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
102,042
+62
| +0.1% | +$722 | ﹤0.01% | 1298 |
|
|
2025
Q1 | $758K | Sell |
101,980
-6,546
| -6% | -$48.6K | ﹤0.01% | 1404 |
|
|
2024
Q4 | $651K | Hold |
108,526
| – | – | ﹤0.01% | 1445 |
|
|
2024
Q3 | $556K | Buy |
108,526
+3,323
| +3% | +$17K | ﹤0.01% | 1478 |
|
|
2024
Q2 | $381K | Buy |
105,203
+4,399
| +4% | +$15.9K | ﹤0.01% | 1576 |
|
|
2024
Q1 | $324K | Sell |
100,804
-48,892
| -33% | -$157K | ﹤0.01% | 1617 |
|
|
2023
Q4 | $734K | Sell |
149,696
-273,770
| -65% | -$1.34M | ﹤0.01% | 1371 |
|
|
2023
Q3 | $2.31M | Sell |
423,466
-131,311
| -24% | -$716K | ﹤0.01% | 1058 |
|
|
2023
Q2 | $3.72M | Sell |
554,777
-67,862
| -11% | -$455K | ﹤0.01% | 957 |
|
|
2023
Q1 | $5.5M | Sell |
622,639
-8,230
| -1% | -$72.7K | 0.01% | 855 |
|
|
2022
Q4 | $4.82M | Buy |
630,869
+53,210
| +9% | +$407K | ﹤0.01% | 872 |
|
|
2022
Q3 | $4.11M | Buy |
577,659
+59,103
| +11% | +$421K | ﹤0.01% | 926 |
|
|
2022
Q2 | $4.2M | Sell |
518,556
-749,517
| -59% | -$6.06M | ﹤0.01% | 938 |
|
|
2022
Q1 | $17.6M | Sell |
1,268,073
-734,571
| -37% | -$10.2M | 0.01% | 695 |
|
|
2021
Q4 | $56.1M | Sell |
2,002,644
-251,084
| -11% | -$7.04M | 0.04% | 450 |
|
|
2021
Q3 | $76.5M | Buy |
2,253,728
+51,843
| +2% | +$1.76M | 0.07% | 365 |
|
|
2021
Q2 | $89.8M | Buy |
2,201,885
+99,140
| +5% | +$4.04M | 0.08% | 330 |
|
|
2021
Q1 | $84.6M | Buy |
2,102,745
+93,441
| +5% | +$3.76M | 0.08% | 329 |
|
|
2020
Q4 | $119M | Buy |
2,009,304
+161,352
| +9% | +$9.54M | 0.12% | 243 |
|
|
2020
Q3 | $89.9M | Buy |
1,847,952
+124,605
| +7% | +$6.06M | 0.11% | 261 |
|
|
2020
Q2 | $83.4M | Buy |
1,723,347
+1,225,502
| +246% | +$59.3M | 0.1% | 268 |
|
|
2020
Q1 | $13.8M | Buy |
+497,845
| New | +$13.8M | 0.02% | 583 |
|